Bottom line
QAAHBX vs IYH: the short answer
QAAHBX (T. Rowe Price Health Sciences Portfolio) and IYH (iShares U.S. Healthcare ETF) are both etfs.
But QAAHBX is far broader, holding 277 positions to 103 for IYH, so beyond the top names it adds exposure IYH doesn't have.
IYH is cheaper at 0.37% vs 1.11% — a difference of $74 a year per $10,000 invested.
Over five years, IYH returned +7.0% a year vs +3.9% for QAAHBX.
Updated Nov 19, 2026
QAAHBX vs IYH side by side
| QAAHBX | IYH | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | T. Rowe Price | iShares |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.11% | 0.37% |
| Annual cost per $10k | $111 | $37 |
| 10-yr cost on $10k (prospectus) | $1,352 | $468 |
| Max front load | None | None |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | +17.8% | +13.1% |
| 5-yr return (annualized) | +3.9% | +7.0% |
| 10-yr return (annualized) | +8.7% | +9.4% |
| Best quarter | +23.4% | +15.3% |
| Worst quarter | −15.8% | −12.7% |
| Net assets (fund) | $751.7M | $3.6B |
| Number of holdings | 277 | 103 |
| Portfolio turnover | 65% | 3% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
15 of QAAHBX's top 25 holdings also appear in IYH's top 25.
| Holding | QAAHBX | IYH |
|---|---|---|
| Eli Lilly & Co | 14.06% | 15.11% |
| Johnson & Johnson | 6.64% | 10.17% |
| Unitedhealth Group Inc | 5.88% | 6.16% |
| Abbvie Inc | 5.12% | 7.32% |
| Merck & Co. Inc. | 4.00% | 5.31% |
| Gilead Sciences Inc | 2.79% | 2.66% |
| Thermo Fisher Scientific Inc | 2.53% | 3.52% |
| Vertex Pharmaceuticals Inc | 2.26% | 2.00% |
| Bristol-myers Squibb Co | 2.12% | 2.20% |
| Abbott Laboratories | 1.91% | 3.02% |
| Intuitive Surgical Inc | 1.89% | 2.05% |
| Amgen Inc | 1.80% | 3.42% |
| Stryker Corp | 1.78% | 1.86% |
| Elevance Health Inc | 1.54% | 1.34% |
| Danaher Corp | 1.44% | 2.03% |
Source: SEC Form N-PORT
QAAHBX top 10
- Eli Lilly & Co — 14.06%
- Johnson & Johnson — 6.64%
- Unitedhealth Group Inc — 5.88%
- Abbvie Inc — 5.12%
- Merck & Co. Inc. — 4.00%
- Gilead Sciences Inc — 2.79%
- Thermo Fisher Scientific Inc — 2.53%
- Vertex Pharmaceuticals Inc — 2.26%
- Bristol-myers Squibb Co — 2.12%
- Abbott Laboratories — 1.91%
IYH top 10
- Eli Lilly And Company — 15.11%
- Johnson & Johnson — 10.17%
- Abbvie Inc. — 7.32%
- Unitedhealth Group Incorporated — 6.16%
- Merck & Co., Inc. — 5.31%
- Thermo Fisher Scientific Incorporated — 3.52%
- Amgen Inc. — 3.42%
- Abbott Laboratories — 3.02%
- Gilead Sciences, Inc. — 2.66%
- Pfizer Inc. — 2.35%
FAQ
What is the difference between QAAHBX and IYH?
Which is cheaper, QAAHBX or IYH?
Should I own both QAAHBX and IYH?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.